Research ArticleOriginal Article
Open Access

Characteristics of re-admitted adult patients infected with severe acute respiratory syndrome Coronavirus 2 After initial hospitalization at King Salman Armed Forces Hospital, Tabuk, Saudi Arabia

Hanaa Albalawi, Rashed Albalawi, Riham Hamza, Abdulaziz Galdagoun, Noura S. Aljofi, Khaled Elgohary and Samira Fallatah
Saudi Medical Journal July 2023, 44 (7) 647-654; DOI: https://doi.org/10.15537/smj.2023.44.7.20220713

References

  1. 1.↵
    1. Cucinotta D,
    2. Vanelli M.
    WHO declares COVID-19 a pandemic. Acta Biomed 2020; 91: 157–160.
    OpenUrlPubMed
  2. 2.↵
    1. Spinelli A,
    2. Pellino G.
    COVID-19 pandemic: perspectives on an unfolding crisis. Br J Surg 2020; 107: 785–787.
    OpenUrlPubMed
  3. 3.↵
    1. Fauci AS,
    2. Clifford LH,
    3. Redfield RR.
    Covid-19-navigating the uncharted. N Engl J Med 2020; 382: 1268–1269.
    OpenUrlCrossRefPubMed
  4. 4.↵
    1. Mahase E,
    2. Kmietowicz Z.
    Covid-19: doctors are told not to perform CPR on patients in cardiac arrest. BMJ 2020 29; 368: m1282.
    OpenUrl
  5. 5.↵
    1. Rodriguez-Morales AJ,
    2. JCardona-Ospina JA,
    3. Gutiérrez-Ocampo E,
    4. Villamizar Peña R,
    5. Holguin-Rivera Y,
    6. JEscalera-Antezana JP, et al
    . Clinical, laboratory and imaging features of COVID-19: A systematic review and meta-analysis.” Travel Med Infect Dis 2020; 34: 101623.
    OpenUrl
  6. 6.
    1. Weiss P,
    2. Murdoch DR
    . Clinical course and mortality risk of severe COVID-19. Lancet 2020; 395: 1014–1015.
    OpenUrlCrossRefPubMed
  7. 7.↵
    1. Wu C,
    2. Chen X,
    3. Cai Y,
    4. Xia J,
    5. Zhou X,
    6. Xu S, et al.
    Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China. JAMA Intern Med 2020;180: 934–943.
    OpenUrl
  8. 8.↵
    1. Somani SS,
    2. Richter F,
    3. Fuster V,
    4. De Freitas J,
    5. Naik N,
    6. Sigel K, et al.
    Characterization of patients who return to hospital following discharge from hospitalization for COVID-19. J Gen Intern Med 2020; 35: 2838–2844.
    OpenUrlPubMed
  9. 9.
    1. Rokadiya S,
    2. Gil E,
    3. Stubbs C,
    4. Bell D,
    5. Herbert R.
    COVID-19: outcomes of patients with confirmed COVID-19 re-admitted to hospital. J Infect 2020; 81: e18–e19.
    OpenUrl
  10. 10.↵
    1. Jeon WH,
    2. Seon JY,
    3. Park SY,
    4. Oh IH
    . Analysis of risk factors on readmission cases of COVID-19 in the Republic of Korea: using nationwide health claims data. Int J Environ Res Public Health 2020;17:5844.
  11. 11.↵
    1. Atalla E,
    2. Kalligeros M,
    3. Giampaolo G,
    4. Mylona EK,
    5. Shehadeh F,
    6. Mylonakis E.
    Readmissions among patients with COVID-19. Int J Clin Pract 2021; 75: e13700.
    OpenUrlPubMed
  12. 12.↵
    1. UyaroĞlu OA,
    2. BaŞaran NÇ,
    3. ÖziŞik L,
    4. Dİzman GT,
    5. EroĞlu İ,
    6. Şahİn TK,
    7. TaŞ Z,
    8. İnkaya AÇ,
    9. TanriÖver MD,
    10. Metan G,
    11. GÜven GS,
    12. Ünal S
    . Thirty-day readmission rate of COVID-19 patients discharged from a tertiary care university hospital in Turkey: an observational, single-center study. Int J Qual Health Care 2021; 33: 144.
  13. 13.↵
    1. Islam MN,
    2. Inan TT,
    3. Raf S,
    4. Akter SS,
    5. Sarker IH,
    6. Islam AN.
    A systematic review on the use of AI and ML for fghting the COVID-19 pandemic. IEEE Trans Artif Intel 2021; 1: 258–270.
    OpenUrl
  14. 14.↵
    1. McCarthy CP,
    2. Murphy S,
    3. Jones-O’Connor M,
    4. Olshan DS,
    5. Khambhati JR,
    6. Rehman S, et al.
    Early clinical and sociodemographic experience with patients hospitalized with COVID-19 at a large American healthcare system. EClinicalMedicine 2020; 26: 100504.
    OpenUrl
  15. 15.↵
    1. Cosdon N.
    Risk factors associated with readmission after COVID-19 hospitalization. Contagion live. [Updated 2021; cited 2021 on October 1] Available at: www.contagionlive.com/view/risk-factors-associated-with-readmission-after-covid-19-hospitalization
  16. 16.↵
    1. Donnelly JP,
    2. Wang XQ,
    3. Iwashyna TJ,
    4. Prescott HC.
    Readmission and death after initial hospital discharge among patients with COVID-19 in a large multihospital system. JAMA 2021; 19: 304–046.
    OpenUrl
  17. 17.↵
    1. Parra LM,
    2. Cantero M,
    3. Morrás I,
    4. Vallejo A,
    5. Diego I,
    6. Jiménez-Tejero E, et al.
    Hospital readmissions of discharged patients with COVID-19. Int J General Med 2020; 13: 1359.
    OpenUrl
  18. 18.↵
    1. Zhou F,
    2. Yu T,
    3. Du R,
    4. Fan G,
    5. Liu Y,
    6. Liu Z, et al.
    Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: A retrospective cohort study. Lancet 2020; 395: 1054–1062.
    OpenUrlCrossRefPubMed
  19. 19.↵
    1. Wu Z,
    2. McGoogan JM.
    Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention. JAMA 2020; 323: 1239–1242.
    OpenUrlCrossRefPubMed
  20. 20.↵
    1. Richardson S,
    2. Hirsch JS,
    3. Narasimhan M,
    4. Crawford JM,
    5. McGinn T,
    6. Davidson KW
    , Northwell COVID-19 Research Consortium Presenting Characteristics, Comorbidities, and Outcomes among 5700 Patients Hospitalized with COVID-19 in the New York City Area. JAMA 2020; 323: 2052–2059.
    OpenUrlCrossRefPubMed
  21. 21.↵
    1. Xiao AT,
    2. Tong YX,
    3. Zhang S.
    False-negative of RT-PCR and prolonged nucleic acid conversion in COVID-19: rather than recurrence. J Med Virol 2020.
  22. 22.
    1. Wong J,
    2. Koh WC,
    3. Momin RN,
    4. Alikhan MF,
    5. Fadillah N,
    6. Naing L.
    Probable causes and risk factors for positive SARS-CoV-2 test in recovered patients: Evidence from Brunei Darussalam. medRxiv. 2020; 92: 1755–1756.
    OpenUrl
  23. 23.↵
    1. Kang H,
    2. Wang Y,
    3. Tong Z,
    4. Liu X.
    Re-test Positive for SARS-CoV-2 RNA of “Recovered” patients with COVID-19: persistence, sampling issues, or re-infection? J Med Virol 2020 92: 2263–2265.
  24. 24.↵
    1. Karnam G,
    2. Rygiel TP,
    3. Raaben M,
    4. Grinwis GC,
    5. Coenjaerts FE,
    6. Ressing ME, et al.
    CD200 receptor controls sex-specific TLR7 responses to viral infection. PLoS Pathog 2012; 8: e1002710.
    OpenUrlCrossRefPubMed
  25. 25.↵
    1. Peretz J,
    2. Pekosz A,
    3. Lane AP,
    4. Klein SL.
    Estrogenic compounds reduce influenza a virus replication in primary human nasal epithelial cells derived from female, but not male, donors. Am J Physiol Lung Cell Mol Physiol 2016; 310: L415–L425.
    OpenUrlCrossRefPubMed
  26. 26.↵
    1. Walter LA,
    2. McGregor AJ.
    Sex-and gender-specific observations and implications for COVID-19. West J Emerg Med 2020; 21: 507–509.
    OpenUrlPubMed
  27. 27.↵
    Korea Centers for Disease Control and Prevention. The Updates on COVID-19 in Korea as of 18 June. [Updated 2020: Accessed 2020 August 11]. Available online: https://www.cdc.go.kr/board/board.es?mid=&bid=0030&tag=&act=view&list_no=367554
  28. 28.↵
    Korea Centers for Disease Control and Prevention The Updates on COVID-19 in Korea as of 18 May. [Updated 2020; Accessed 2020 August 11]. Available from: http://nih.go.kr/board/board.es?mid=a30402000000&bid=0030&act=view&list_no=367251&tag=&nPage=1
  29. 29.↵
    1. Ravioli S,
    2. Ochsner H,
    3. Lindner G.
    Reactivation of COVID-19 Pneumonia: A report of two cases. J Infect 2020; 12: 12.
    OpenUrl
  30. 30.↵
    1. Parra LM,
    2. Cantero M,
    3. Morrás I,
    4. Vallejo A,
    5. Diego I,
    6. Jiménez-Tejero E, et al.
    Hospital readmissions of discharged patients with COVID-19. Int J General Med 2020; 13: 1359.
    OpenUrl
  31. 31.↵
    1. Chen J,
    2. Xu X,
    3. Hu J,
    4. Chen Q,
    5. Xu F,
    6. Liang H, et al.
    Clinical course and risk factors for recurrence of positive SARS-CoV-2 RNA: A retrospective cohort study from Wuhan, China. Aging (Albany NY) 2020; 12: 16675–16689.
    OpenUrl
  32. 32.↵
    1. Nematshahi M,
    2. Soroosh D,
    3. Neamatshahi M,
    4. Attarian F,
    5. Rahimi F.
    Factors predicting readmission in patients with COVID-19. BMC Res Notes 2021; 14: 374.
    OpenUrlCrossRef
  33. 33.↵
    1. Cao B,
    2. Wang Y,
    3. Wen D,
    4. Liu W,
    5. Wang J,
    6. Fan G, et al.
    A trial of lopinavir–ritonavir in adults hospitalized with severe Covid-19. N Engl J Med 2020; 382: 1787–1799.
    OpenUrlCrossRefPubMed
Back to top

In this issue

Print
Download PDF
Email Article
Citation Tools
Bookmark this article

Jump to section

Keywords